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Protein phosphatase 1 (PP1) interacts with 200 regulatory proteins to form holoenzymes, which
target PP1 to speciﬁc locations and regulate its speciﬁcity. While it is known that many PP1 regula-
tory proteins are dynamic in the unbound state, much less is known about the residual ﬂexibility
after PP1 holoenzyme formation. Here, we have used small angle X-ray scattering to investigate
the ﬂexibility of the PP1:spinophilin holoenzyme in solution. Collectively, our data shows that the
PP1:spinophilin holoenzyme is dynamic in solution, which allows for an increased capture radius
of spinophilin and is likely important for its biological role.
Structured summary:
MINT-8057915: PP1-alpha (uniprotkb:P62136) and Spinophilin (uniprotkb:O35274) bind (MI:0407) by x
ray scattering (MI:0826)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Protein phosphatase 1 (PP1) is a key serine/threonine phospha-
tase for regulating numerous essential cellular events including
glycogen metabolism, neuronal signaling and protein synthesis
[1]. However, PP1 itself exhibits very little substrate speciﬁcity. In-
stead, speciﬁcity is achieved by its interaction with 200 different
regulatory proteins that associate with PP1 to form highly speciﬁc
holoenzymes [2]. Interestingly, PP1 regulatory proteins are often
highly dynamic and lack a common 3-dimensional fold in their un-
bound forms, and thus belong to the class of proteins known as
intrinsically unstructured proteins [3–5]. This ﬂexibility is vital
for their biological functions, as it allows them to interact through
extensive interaction surfaces with PP1, where they commonly
bind with signiﬁcantly reduced ﬂexibilities [4,6]. However, some
regulators retain a signiﬁcant degree of ﬂexibility even after bind-
ing PP1 [6,7]. For example, the residual ﬂexibility upon binding PP1
is essential for the proper regulation of PP1 by Inhibitor-2 [7]. Cur-
rently, the number of PP1 regulatory proteins with residual ﬂexi-
bility when bound to PP1, as well as the role of this ﬂexibility in
their biological functions, is unclear.
Spinophilin is a multi-domain scaffolding protein that targets
PP1 to the post synaptic density (PSD) through its interaction withchemical Societies. Published by E
ti).F-actin [8]. In the PSD, the PP1:spinophilin complex is additionally
targeted to AMPA receptors via its PDZ domain, which is immedi-
ately C-terminal to the PP1-binding domain [9]. Once localized, the
holoenzyme dephosphorylates Ser845 on the GluR1 subunit of
AMPA receptors thereby regulating long term depression, a process
critical for learning and memory formation [10].
Recently, we determined the 3-dimensional structure of the
PP1:spinophilin holoenzyme [4]. Although the spinophilin PP1-
binding domain is intrinsically unstructured in its unbound state,
it folds upon binding to PP1 into a single, stable conformation.
Notably, in the crystal, two molecules of the PP1:spinophilin holo-
enzyme were present in the asymmetric unit [4]. Interestingly, the
structure of the spinophilin PP1 binding domain is identical be-
tween the two molecules in the asymmetric unit. In contrast,
strong continuous electron density was only observed for one of
the spinophilin PDZ domains. The fact that essentially no electron
density was observed for the second PDZ domain, suggests that it
was dynamic in respect to the spinophilin PP1-binding domain in
the crystal. This also suggests that the residues connecting the
spinophilin PP1-binding and PDZ domains are ﬂexible, allowing
the two domains to rotate independently of one another. Further-
more, the ﬁrst, ordered spinophilin PDZ domain forms extensive
crystal contacts with a PP1 symmetry mate, and thus crystal pack-
ing also likely contributes to the additional reduced ﬂexibility be-
tween the spinophilin PP1-binding and PDZ domains (Fig. 1). Thus,
to investigate the ﬂexibility and structure of the PP1:spinophilinlsevier B.V. All rights reserved.
Fig. 1. (a) The PP1:spinophilin holoenzyme structure (PDB ID: 3EGG): PP1 (blue surface), spinophilin PP1-binding domain (red, cartoon), spinophilin PDZ domain (purple,
cartoon). (b) Two PP1:spinophilin symmetry mates are shown as gray surface representations to highlight the crystal packing around the spinophilin PDZ domain. (c) 135
rotation of (b).
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(SAXS) data.
2. Materials and methods
2.1. Protein expression and puriﬁcation
PP1a7–330 and spinophilin417–583 were expressed as described
[4]. The PP1a7–330:spinophilin417–583 complex was puriﬁed using
a previously described protocol [4] with the following changes.
After elution from Ni-NTA resin (Qiagen), the PP1:spinophilin com-
plex was puriﬁed using a Superdex 200 26/60 size exclusion col-
umn (GE Healthcare) equilibrated with PP1 complex buffer
(20 mM Tris pH 7.5, 50 mM NaCl, 0.5 mM TCEP). Tobacco Etch
Virus protease (TEV) was added to cleave the His6-tag from
PP1a7–330. After digestion was complete, subtraction puriﬁcation
was performed using Ni-NTA resin (Qiagen) for the removal of
TEV and the cleaved His6-tag. In the ﬁnal puriﬁcation step, the
complex was puriﬁed using a Superdex 75 26/60 size exclusion
column (GE Healthcare) equilibrated with PP1 complex buffer.
Fractions containing protein, as veriﬁed by SDS–PAGE, were pooled
and stored at 4 C.
2.2. SAXS measurements
The PP1:spinophilin holoenzyme sample used for all SAXS mea-
surements was produced within 24 h of data acquisition and
stored at 4 C. Immediately prior to the SAXS experiments, the
sample was concentrated to either 0.5 mg/ml or 0.9 mg/ml at
4 C and ﬁltered through a 0.02 lm ﬁlter (Whatman). Synchrotron
X-ray scattering data were collected at the National Synchrotron
Light Source (NSLS) beamline X9. SAXS data were collected using
a MarCCD 165 located at 3.4 m distance from the sample. Wide an-
gle X-ray scattering (WAXS) data were collected simultaneously
with SAXS data using a Photonic Science CCD located at 0.47 m
from the sample. 20 ll of sample was continuously pushed
through a 1 mm diameter capillary for 180 s of measurement time
and exposed to a 400  200 lm X-ray beam. Scattering data for the
complex was collected at concentrations of 0.5 mg/ml and 0.9 mg/
ml. Normalization for beam intensity, buffer subtraction and merg-
ing of the data from both detectors were carried out using PRIMUS
[11]. Theoretical scattering for the PP1:spinophilin crystal struc-
ture was calculated using FOXS [12]. A Guinier approximation,
I(q) = I(0)exp(q2Rg2/3), where a plot of ln (I(q)) and q2 is linear
for q < 1.3/Rg, was performed on four independent scattering trialsand averaged to determine the radius of gyration [13]. GNOM was
used to determine the pair distribution function [P(r)] and maxi-
mum particle dimension (Dmax) [14]. HYDROPRO was used to cal-
culate the Rg and the distribution of distances for the
PP1:spinophilin crystal structure for direct comparison with the
Rg from the Guinier approximation and P(r), respectively [15].
The linearity of the Guinier region and the forward scattering
intensity were used to validate that the PP1:spinophilin complex
sample was monodisperse in solution. The forward scattering
intensity, I(0), is the theoretical scattering at a q value of 0 and is
proportional to the molecular weight of the sample [16]. I(0)/c,
where c is concentration, was identical for all PP1:spinophilin mea-
surements, demonstrating that the molecular weight of the com-
plex does not change with increasing protein concentration.
2.3. BILBOMD
BILBOMD [17] was used to investigate the ﬂexibility of the
PP1:spinophilin complex. Molecular dynamics (MD) simulations
in BILBOMD were used to generate 12,000 structures with a Rg
range of 20–50 Å (200 structures/Å; 2 calculations) [17]. Theoreti-
cal scattering curves were calculated for each structure using FOXS
and compared to the experimental SAXS data [12]. The single best
ﬁt structure is deﬁned as the structure with the lowest discrepancy
(v2) between the theoretical and experimental data. A minimal
ensemble (MES) model was generated as previously described
[17]. The MES was selected as the best model for the PP1:spinophi-
lin complex in solution. The program DynDom was used to deter-
mine the spinophilin PDZ domain rotation between the crystal
structure and the MES [18].
3. Results
3.1. The PP1:spinophilin complex is more extended in solution
Theoretical scattering data based on the PP1:spinophilin crystal
structure and experimental scattering data correlate poorly with a
discrepancy value (v2) of 3.70. This shows that the complex adopts
a different conformation in solution than in the crystal (Fig. 2a).
Similarly, the radius of gyration (Rg) of the PP1:spinophilin complex
in solution (29.1 ± 0.4 Å, as determined by the Guinier approxima-
tion) is 3.4 Å larger than the Rg calculated from the crystal structure
(25.7 Å) (Fig. 2a). We determined the pair distance distribution
function P(r), which is the distribution of all interatomic distances
in the PP1:spinophilin complex, using GNOM (Fig. 2b). Not surpris-
Fig. 2. (a) SAXS data for the PP1:spinophilin holoenzyme is shown as black squares with error bars as grey lines. Guinier plots for 0.5 mg/ml and 0.9 mg/ml are shown as an
inset. (b) The P(r) of the PP1:spinophilin complex from SAXS data (black line) and based on the crystal structure (blue, dashed line).
Fig. 3. (a) Rg for each BILBOMD conformer plotted against the v2. (b) Comparison of the theoretical scattering of the single best ﬁt model (red line) and the experimental data
(black squares).
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the complex is elongated in solutionwith a Rg of 29.05 Å and amax-
imal dimension of 90 Å. The agreement between the Guinier de-
rived Rg and P(r) derived Rg is excellent, as expected for high-
quality SAXS data. A comparison of the PP1:spinophilin solution
P(r) with the distribution of distances in the PP1:spinophilin crystal
structure, as determined using HYDROPRO, is shown in Fig. 2b. The
overall shape of the PP1:spinophilin P(r) is conserved between the
crystal structure and the solution data. However, the P(r) function
for the crystal structure falls to zero at shorter distances than the
solution P(r). Taken together, the differences observed in the Rg
and P(r) between the PP1:spinophilin holoenzyme solution and
crystal data demonstrates that the PP1:spinophilin complex adopts
a more extended structure in solution.
3.2. BILBOMD analysis
To further investigate the conformation of the PP1:spinophilin
holoenzyme in solution, we used the program BILBOMD. BILBOMDsamples conformational space using molecular dynamics (MD)
simulations and then selects for the models that have the best
agreement between the theoretical and experimental scattering
data [17]. The PP1:spinophilin crystal structure (PDBID:3EGG)
was used as a starting model for the MD simulations. Spinophilin
residues 490–494, which form a linker between the PP1-binding
and the PDZ domain and for which no electron density was ob-
served in one molecule in the asymmetric unit of the PP1:spino-
philin crystal, were deﬁned as ﬂexible. PP1 and spinophilin
residues 424–489 were deﬁned as a single ﬁxed entity in space,
while the spinophilin PDZ domain was deﬁned as a rigid body that
was allowed to move with respect to PP1. Despite deﬁning a Rg
range of 20–50 Å for the simulations, only structures with a Rg be-
tween 23 and 32 Å were sampled in the MD calculations, showing
a limited ﬂexibility between the spinophilin PP1-binding and PDZ
domain (Fig. 3a). The single best ﬁt model has a Rg of 27.0 Å. The
theoretical scattering proﬁle for this model is in good agreement
with the experimental scattering data (v2 = 1.30), a signiﬁcant
improvement over the crystal structure ﬁt (v2 = 3.70) (Fig. 3b).
Fig. 4. (a) Comparison of the structure of spinophilin in the crystal structure (red) and the single best ﬁt structure from BILBOMD (blue). The ﬂexible linker of spinophilin
(residues 490–494) is colored in yellow. (b, c) A comparison of single best ﬁt structure (blue) with the two additional conformers which form the MES model (green and
purple). The axis of rotation is shown as a blue line and the angle of rotation is indicated.
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A minimal ensemble model (MES) was created that includes the
single best ﬁt model (73%) as well as two additional models (15%
and 12%). The MES does not improve the overall ﬁt to the experi-
mental scattering data, but it demonstrates that an ensemble of
structures ﬁts the data equally well (v2 = 1.30). In the MES model,
the spinophilin PDZ domain is 18 Å extended away from the PP1
hydrophobic substrate binding groove and rotated by 140 ± 10
relative to the position of the PDZ domain in the crystal structure
(Fig. 4a). All three structures that form the MES are related by a
rotation around the ﬂexible spinophilin linker (residues 490–494)
without a signiﬁcant movement of the PDZ domain relative to
PP1 (Fig. 4b and c). The most likely reason for the MES v2P 1 ﬁt
is the ﬂexible C-terminal tail of PP1 (residues 300–330), which
was present throughout all SAXS experiments, but not used in
the BILBOMD calculations.
4. Discussion
Using SAXS, we have demonstrated that the PP1:spinophilin
complex adopts a signiﬁcantly more extended conformation in
solution than in the crystal structure, where this extension is re-
stricted by crystal packing. The extended solution structure is the
result of a ﬂexible linker between the spinophilin PP1-binding
and the PDZ domain (residues 490–494). This allows the spinophi-
lin PDZ domain to move relative to the PP1-binding domain, which
becomes ﬁxed in a single conformation upon PP1 holoenzyme
complex formation. Since the theoretical scattering data of the
MES model and the experimental scattering data agree very well,
the dynamics within the PP1:spinophilin complex is likely re-
stricted to the ﬂexible linker connecting the spinophilin PP1-bind-
ing and PDZ domains.
The ﬂexibility between the spinophilin PP1-binding and PDZ
domains is important for three reasons. First, the BILBOMD MES
ensemble structure demonstrates that the spinophilin PDZ domain
does not extend any of the three recognized substrate bindinggrooves on PP1. Thus, the PDZ domain will not create an additional
binding site for PP1:spinophilin holoenzyme substrates. This is in
excellent agreement with biochemical data, which showed that
the spinophilin PDZ domain does not enhance binding to PP1 or
play a role in substrate recognition [9,19]. Second, our results sug-
gest that the spinophilin PDZ domain acts independently from the
spinophilin PP1-binding domain, despite the short four residue lin-
ker. This provides further corroboration that the PDZ domain likely
behaves solely as a targeting domain. Third, the four residue ﬂexi-
bility in the PP1:spinophilin holoenzyme will increase the capture
radius of the spinophilin PDZ domain for its biological targets, for
example, the GluR2/3 subunits of the AMPA receptor. The in-
creased capture radius likely allows for more efﬁcient targeting
of the PP1:spinophilin holoenzyme in vivo.
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